Lundbeck
HLUN-B.CO
#2544
Rank
A$8.63 B
Marketcap
$9.06
Share price
0.05%
Change (1 day)
26.99%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2024 (TTM): A$0.84 Billion

According to Lundbeck 's latest financial reports the company's current earnings are A$3.18 Billion. , an increase over its 2023 earnings that were of A$0.70 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2024

Annual earnings

Year Earnings Change
2024 A$0.87 B25.46%
2023 A$0.70 B21.69%
2022 A$0.57 B31.79%
2021 A$0.43 B-4.53%
2020 A$0.45 B-45.08%
2019 A$0.83 B-33.97%
2018 A$1.26 B12.76%
2017 A$1.11 B94.32%
2016 A$0.57 B-136.98%
2015 -A$1.56 Billion-1258.1%
2014 A$0.13 B-72.43%
2013 A$0.48 B4.31%
2012 A$0.46 B-55.26%
2011 A$1.04 B6.64%
2010 A$0.97 B-6.68%
2009 A$1.04 B